1. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer
- Author
-
Naoshi Kubo, Masaichi Ohira, Mami Yoshii, Katsunobu Sakurai, Masakazu Yashiro, Hiroaki Tanaka, Tatsuro Tamura, Shigeru Lee, Kazuya Muguruma, and Takahiro Toyokawa
- Subjects
Male ,Cancer Research ,Multivariate analysis ,Kaplan-Meier Estimate ,Gastroenterology ,0302 clinical medicine ,Surgical oncology ,Platelet to lymphocyte ratio ,C-reactive protein to albumin ratio ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Prognosis ,C-Reactive Protein ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Preoperative Period ,030211 gastroenterology & hepatology ,Female ,Research Article ,medicine.medical_specialty ,Serum Albumin, Human ,lcsh:RC254-282 ,03 medical and health sciences ,Gastrectomy ,Stomach Neoplasms ,Internal medicine ,Genetics ,medicine ,Biomarkers, Tumor ,Humans ,Clinical significance ,Lymphocyte Count ,Neutrophil to lymphocyte ratio ,Nutrition ,Aged ,Neoplasm Staging ,Retrospective Studies ,Inflammation ,Receiver operating characteristic ,Proportional hazards model ,business.industry ,Platelet Count ,Cancer ,Retrospective cohort study ,medicine.disease ,Nutrition Assessment ,ROC Curve ,business ,Gastric cancer ,Follow-Up Studies - Abstract
Background Although many studies have identified several inflammation-based and/or nutritional markers with prognostic value for patients with various types of cancer, the optimal markers and cut-off values for these markers remain obscure. Therefore, this retrospective study aimed to identify optimal markers and their cutoffs. Methods We compared prognostic values among established preoperative inflammation-based and/or nutritional markers in 225 patients who underwent R0 resection for stage III gastric cancer. Inflammation-based and/or nutritional markers comprised C-reactive protein to albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), prognostic nutritional index (PNI), Glasgow prognostic score (GPS), and prognostic index (PI). Time-dependent receiver operating characteristic curves were analyzed to assess predictive ability and to determine the optimal cut-off values. Prognostic factors predicting overall survival (OS) and cancer specific survival (CSS) were analyzed using Cox proportional hazards models. Results Multivariate analyses revealed that CAR and PLR cut-off values of 0.47 and 172, respectively, were independent prognostic factors for overall survival (OS) (HR, 2.257; 95% CI, 1.180–4.319; p = 0.014 and HR, 1.478; 95% CI, 1.025–2.133; p = 0.037, respectively) and cancer-specific survival (CSS) (HR, 2.771; 95% CI, 1.398–5.493; p = 0.004 and HR, 1.552; 95% CI, 1.029–2.341; p = 0.036, respectively). These results were different from those we previously reported in patients with stage II. Conclusions Among inflammation-based and/or nutritional markers, CAR and PLR were independent prognostic factors of OS and CSS in patients with stage III gastric cancer. The optimal markers and their cut-off values should be determined in specific populations.
- Published
- 2020